ONCOLOGY RCC TEAM WILL NOT GET PALBO

Discussion in 'Pfizer' started by Anonymous, Aug 11, 2014 at 6:28 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I heard through multiple channels that the RCC team will not get Palbo if & when approved. Punishment for not hitting the OBU expectation with Inlyta. Sophisticated way to get rid of quite alot of people without having to go through a true reduction/severance. Must be Dems running the OBU, what am I saying... they all act the same way. New world we live in. Im just a squirrel trying to scratch my nuts..
     

  2. Anonymous

    Anonymous Guest

    Heard this from my DBM the other day. These folks, must have learned about motivation from Stalin.
     
  3. Anonymous

    Anonymous Guest

    Wow
     
  4. Anonymous

    Anonymous Guest

    Not true in the slightest.
     
  5. Anonymous

    Anonymous Guest

    Makes sense cause the lung team has had so much success hitting their xalkori target, (no fault of their own, just stupid quota expectations made by equally stupid people). Keep trolling
     
  6. Anonymous

    Anonymous Guest

    Whatever...

    ...the OBU needs $$$$$

    Then good things will follow.
     
  7. Anonymous

    Anonymous Guest

    You can't say that quota is too high or that it isn't the rep's fault.

    Nobody was ready for this market and the challenges it presented. The challenges still exist. It probably won't improve until 2-3 more targeted therapies hit the market.

    It's a bitch.